A detailed history of Guardian Capital LP transactions in Johnson & Johnson stock. As of the latest transaction made, Guardian Capital LP holds 128,568 shares of JNJ stock, worth $19.9 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
128,568
Previous 133,344 3.58%
Holding current value
$19.9 Million
Previous $19.5 Million 6.91%
% of portfolio
0.84%
Previous 0.81%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $694,812 - $799,406
-4,776 Reduced 3.58%
128,568 $20.8 Million
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $59,917 - $65,478
415 Added 0.31%
133,344 $19.5 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $18,781 - $19,691
-121 Reduced 0.09%
132,929 $21 Million
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $233,105 - $254,366
-1,601 Reduced 1.19%
133,050 $20.9 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $11.1 Million - $12.4 Million
-71,118 Reduced 34.56%
134,651 $21 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $12,502 - $13,454
-81 Reduced 0.04%
205,769 $34.1 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $627,612 - $748,980
-4,155 Reduced 1.98%
205,850 $31.9 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $148,505 - $166,665
927 Added 0.44%
210,005 $37.1 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $3.24 Million - $3.6 Million
20,077 Added 10.62%
209,078 $34.2 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $5.86 Million - $6.49 Million
-34,871 Reduced 15.58%
189,001 $33.6 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $714,002 - $810,848
4,515 Added 2.06%
223,872 $39.7 Million
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $2.59 Million - $2.87 Million
16,586 Added 8.18%
219,357 $37.5 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $1.43 Million - $1.59 Million
-8,854 Reduced 4.18%
202,771 $32.7 Million
Q2 2021

Aug 17, 2021

BUY
$159.48 - $171.07 $53,585 - $57,479
336 Added 0.16%
211,625 $34.9 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $8.59 Million - $9.56 Million
56,101 Added 36.15%
211,289 $34.7 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $27,970 - $32,105
-204 Reduced 0.13%
155,188 $24.4 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $102,617 - $112,449
-731 Reduced 0.47%
155,392 $23.1 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $5.54 Million - $6.68 Million
-42,980 Reduced 21.59%
156,123 $22 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $3.11 Million - $4.3 Million
27,945 Added 16.33%
199,103 $26.1 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $4.71 Million - $5.41 Million
-36,932 Reduced 17.75%
171,158 $25 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $605,678 - $678,149
-4,771 Reduced 2.24%
208,090 $26.9 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $577,584 - $635,232
-4,404 Reduced 2.03%
212,861 $29.6 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $1.26 Million - $1.4 Million
-10,001 Reduced 4.4%
217,265 $30.4 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $1.19 Million - $1.43 Million
-9,675 Reduced 4.08%
227,266 $29.3 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $364,861 - $428,782
-3,001 Reduced 1.25%
236,941 $32.7 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $649,774 - $717,037
5,442 Added 2.32%
239,942 $29.1 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $265,212 - $314,056
-2,120 Reduced 0.9%
234,500 $30.1 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $29,655 - $32,458
-226 Reduced 0.1%
236,620 $33.1 Million
Q3 2017

Nov 15, 2017

SELL
$129.47 - $135.38 $545,974 - $570,897
-4,217 Reduced 1.75%
236,846 $30.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
241,063
241,063 $31.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Guardian Capital LP Portfolio

Follow Guardian Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital LP with notifications on news.